ASX Share rice
Thu 13 May 2021 - 01:12:pm (Sydney)

EX1 Share Price

EXOPHARM LIMITEDEX1Pharmaceuticals, Biotechnology & Life Sciences

EX1 Company Information


Exopharm Limited






31 Queen Street Melbourne VIC Australia 3000


61 3 9111 0026

Full Time Employees:


Company Founder, Technology Co-Founder, MD & Director:

Dr. Ian E. Dixon M.A.I.C.D., M.B.A., MBA, Ph.D.

Chief Operating Officer:

Dr. Gregor Lichtfuss M.Sc.

Chief Commercial Officer:

Dr. Christopher Baldwin Ph.D.

Company Sec. & Non-Exec. Director:

Ms. Elizabeth McGregor B.A., M.B.A.

Company Overview:

Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing human therapeutics using extracellular vesicles (EVs) as medicines in Australia. The company is developing Naïve EVs as regenerative medicines, including Plexaris for wound healing; and Cevaris used in inflammatory, immunomodulatory, and tissue remodeling activities. Its Engineered EVs products comprise Fortrexo CoV, an engineered EV product that reduce the duration and severity of SARS-CoV-2 infection in the early phase of a patient's exposure to COVID-19; and Plexodox, a platelet derived EV loaded with the approved anti-cancer drug doxorubicin as a novel and improved anticancer drug. The company was founded in 2013 and is headquartered in Melbourne, Australia.

EX1 Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


EX1 CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Sale Purchase Of Stock:


Capital Expenditures:


EX1 Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Total Revenue:


EX1 Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


EX1 Share Price History

EX1 News

10 May, 2021
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
20 Feb, 2021
Unless you borrow money to invest, the potential losses are limited. On the other hand, if you find a high quality...
25 Aug, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...